Analysis of change in ultracentrifugal lipoprotein profiles following heparin and ethyl-p-chlorophenoxyisobutyrate administration.
D000368:Aged; D001786:Blood Glucose; D002087:Butyrates / Q000627:therapeutic use*; D002499:Centrifugation, Density Gradient; D003201:Computers; D003864:Depression, Chemical; D005215:Fasting; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008722:Methods; D008875:Middle Aged; D013997:Time Factors; D014461:Ultracentrifugation
D001786:Blood Glucose; D002087:Butyrates; D008074:Lipoproteins; D006493:Heparin